Lymphedema and chronic venous insufficiency (CVI) pose a unique set of challenges for clinicians and patients. There is currently no cure for these chronic progressive conditions and, if left untreated, they can lead to cellulitis (recurrent infections), fibrosis (progressive hardening and thickening of the skin), decreased mobility and dexterity, and increased pain.
Tactile Medical provides lymphedema and CVI solutions that treat the whole body. Each is designed for effective, consistent use at home. Another differentiator is that unlike other durable medical equipment companies, we manufacture, distribute and service our products.
To help patients receive the most effective lymphedema home treatment available, Tactile Medical works with thousands of third-party payers across the country. Our solutions are reimbursed by the majority of health plans, including Medicare, Veterans Affairs and private health plans representing more than 270 million lives.
Contact us to learn how much our solutions can save your health plan.
Clinical research is fundamental to Tactile Medical’s mission of advancing the standard of at-home treatment of lymphedema and venous ulcers. Our commitment to research has resulted in a growing body of clinical evidence that includes more than 19 clinical studies and 24 peer-reviewed articles. We encourage you to explore our clinical evidence.
Each system includes a controller unit and relevant garment(s):
Call us at 1.833.3TACTILE (1-833-382-2845)
7:00 a.m. to 7:00 p.m. CT, Monday through Friday and 8:00 a.m. to 12:00 p.m. CT, Saturday
1.Dean S, Valenti E, Hock K, Leffler J, Compston A, Abraham W. The Clinical Characteristics of Lower Extremity Lymphedema in 440 Patients. Jour of Vasc Surg: Venous & Lymph Disorders. ePublished Feb 2020. Data on file at Tactile Medical
2. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner S. Flexitouch – The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients with Lymphedema, JAMA Dermatology, October 2015.